Ross A Soo Selected Research

Ross A Soo Research Topics

Disease

75	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2003
39	Neoplasms (Cancer) 01/2024 - 08/2003
21	Lung Neoplasms (Lung Cancer) 03/2021 - 07/2008
9	Disease Progression 05/2023 - 10/2011
6	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2017
6	Adenocarcinoma 05/2023 - 04/2008
5	Brain Neoplasms (Brain Tumor) 05/2023 - 03/2016
4	Adenocarcinoma of Lung 01/2017 - 03/2013
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2020
3	Fatigue 10/2019 - 08/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015 - 03/2013
2	Melanoma (Melanoma, Malignant) 01/2024 - 03/2015
2	Mesothelioma 01/2024 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2023 - 01/2018
2	Carcinogenesis 01/2023 - 10/2014
2	Pneumonia (Pneumonitis) 11/2022 - 01/2018
2	Neutropenia 01/2022 - 11/2020
2	Carcinoma (Carcinomatosis) 10/2019 - 10/2015
2	Lymphoma (Lymphomas) 01/2016 - 03/2012
1	Triple Negative Breast Neoplasms 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Stomach Neoplasms (Stomach Cancer) 12/2023
1	Hypertriglyceridemia 05/2023
1	Edema (Dropsy) 05/2023
1	Hypercholesterolemia 05/2023
1	Febrile Neutropenia 01/2022
1	Pulmonary Tuberculosis 01/2020
1	Hepatitis B 01/2020
1	Squamous Cell Carcinoma of Head and Neck 10/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019

Drug/Important Bio-Agent (IBA)

26	Tyrosine Kinase InhibitorsIBA 12/2023 - 04/2008
24	ErbB Receptors (EGF Receptor)IBA 10/2023 - 04/2008
12	Anaplastic Lymphoma KinaseIBA 12/2023 - 11/2012
11	Immune Checkpoint InhibitorsIBA 05/2023 - 03/2015
10	lorlatinibIBA 12/2023 - 12/2018
8	Gefitinib (Iressa)FDA Link 12/2023 - 04/2008
8	CrizotinibIBA 05/2023 - 04/2012
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
7	Gemcitabine FDA Link 05/2018 - 08/2003
6	osimertinibIBA 10/2023 - 01/2018
5	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 08/2003
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2014
5	PlatinumIBA 10/2023 - 01/2016
5	NivolumabIBA 03/2022 - 03/2015
5	AfatinibIBA 12/2020 - 10/2012
4	durvalumabIBA 07/2023 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2012
4	Docetaxel (Taxotere)FDA Link 03/2022 - 11/2020
3	lazertinibIBA 12/2023 - 10/2023
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2018 - 04/2008
3	Phosphotransferases (Kinase)IBA 01/2017 - 03/2012
3	linifanibIBA 02/2015 - 08/2011
2	spartalizumabIBA 01/2024 - 01/2022
2	Trastuzumab (Herceptin)FDA Link 12/2023 - 01/2022
2	pembrolizumabIBA 05/2023 - 12/2015
2	B7-H1 AntigenIBA 01/2023 - 12/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 02/2015
2	Monoclonal AntibodiesIBA 09/2021 - 01/2010
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2019 - 03/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2015 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 08/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 11/2012
2	gemcitabine triphosphateIBA 12/2008 - 07/2008
1	Cytochrome P-450 CYP2C9IBA 12/2023
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 12/2023
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2023
1	SteroidsIBA 12/2023
1	Etoposide (VP 16)FDA LinkGeneric 11/2023
1	atezolizumabIBA 11/2023
1	cyclo(Arg-Pro) (CI 4)IBA 05/2023
1	CytokinesIBA 01/2023
1	InterleukinsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	ElectrolytesIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	lenvatinibIBA 01/2022
1	3- ((3- ((4- (4- morpholinylmethyl)- 1H- pyrrol- 2- yl)methylene)- 2- oxo- 2,3- dihydro- 1H- indol- 5- yl)methyl)- 1,3- thiazolidine- 2,4- dioneIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	Sunitinib (Sutent)FDA Link 11/2020
1	Mevalonic Acid (Mevalonate)IBA 12/2019
1	cerivastatin (Kazak)FDA Link 12/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2019
1	Messenger RNA (mRNA)IBA 10/2019
1	Lipase (Acid Lipase)FDA Link 10/2019
1	RogaratinibIBA 10/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019

Therapy/Procedure

28	Therapeutics 01/2024 - 08/2003
23	Drug Therapy (Chemotherapy) 11/2023 - 01/2010
6	Immunotherapy 05/2023 - 08/2014
3	Molecular Targeted Therapy 01/2017 - 03/2015
2	Time-to-Treatment 09/2019 - 01/2019
2	Radiotherapy 01/2017 - 01/2017
1	Overlapping Surgery 01/2023
1	Combined Modality Therapy 01/2023
1	Chemoradiotherapy 11/2022
1	Neoadjuvant Therapy 01/2022
1	Drug Tapering 01/2019